ArticleFrontiers in oncology2022

Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: Perioperative and Survival Outcomes.

Xiao Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.